Cross-dressing: An alternative mechanism for antigen presentation

Immunology Letters

Volumn 168, Issue 2, 2015, Pages 349-354

  Campana, Stefania ^a   De Pasquale, Claudia ^a   Carrega, Paolo ^b   Ferlazzo, Guido ^a,c   Bonaccorsi, Irene ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Antigen presentation; Cross dressing; Dendritic cells; Exosomes; Trogocytosis; Tunneling nanotubes

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NANOTUBE; TUMOR ANTIGEN; ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN CROSS DRESSING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL COMMUNICATION; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; ENDOCYTOSIS; EXOSOME; HELPER CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TROGOCYTOSIS; BIOLOGICAL MODEL; DENDRITIC CELL; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS; CROSS-PRIMING; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MODELS, IMMUNOLOGICAL;

EID: 84949548477     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2015.11.002     Document Type: Review

References (76)

1. Cone R.E., Sprent J., Marchalonis J.J. Antigen-binding specificity of isolated cell-surface immunoglobulin from thymus cells activated to histocompatibility antigens. Proc. Natl. Acad. Sci. U. S. A. 1972, 69:2556-2560.
2. Arnold P.Y., Mannie M.D. Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells. Eur. J. Immunol. 1999, 29:1363-1373.
3. Hudrisier D., Riond J., Mazarguil H., Gairin J.E., Joly E. Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J. Immunol. 2001, 166:3645-3649.
4. Patel D.M., Arnold P.Y., White G.A., Nardella J.P., Mannie M.D. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J. Immunol. 1999, 163:5201-5210.
5. Joly E., Hudrisier D. What is trogocytosis and what is its purpose?. Nat. Immunol. 2003, 4:815.
6. Davis D.M. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat. Rev. Immunol. 2007, 7:238-243.
7. Thery C., Duban L., Segura E., Veron P., Lantz O., Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 2002, 3:1156-1162.
8. Andre F., Chaput N., Schartz N.E., Flament C., Aubert N., Bernard J., Lemonnier F., Raposo G., Escudier B., Hsu D.H., Tursz T., Amigorena S., Angevin E., Zitvogel L. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 2004, 172:2126-2136.
9. Ahmed K.A., Munegowda M.A., Xie Y., Xiang J. Intercellular trogocytosis plays an important role in modulation of immune responses. Cell. Mol. Immunol. 2008, 5:261-269.
10. Thery C., Zitvogel L., Amigorena S. Exosomes composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2:569-579.
11. Rechavi O., Goldstein I., Kloog Y. Intercellular exchange of proteins: the immune cell habit of sharing. FEBS Lett. 2009, 583:1792-1799.
12. Smyth L.A., Afzali B., Tsang J., Lombardi G., Lechler R.I. Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance. Am. J. Transpl. 2007, 7:1442-1449.
13. Dhainaut M., Moser M. Regulation of immune reactivity by intercellular transfer. Front. Immunol. 2014, 5:112.
14. Roda-Navarro P., Reyburn H.T. Intercellular protein transfer at the NK cell immune synapse: mechanisms and physiological significance. FASEB J. 2007, 21:1636-1646.
15. Bonaccorsi I., Morandi B., Antsiferova O., Costa G., Oliveri D., Conte R., Pezzino G., Vermiglio G., Anastasi G.P., Navarra G., Munz C., Di Carlo E., Mingari M.C., Ferlazzo G. Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. J. Immunol. 2014, 192:824-832.
16. de Heusch M., Blocklet D., Egrise D., Hauquier B., Vermeersch M., Goldman S., Moser M. Bidirectional MHC molecule exchange between migratory and resident dendritic cells. J. Leukoc. Biol. 2007, 82:861-868.
17. Herrera O.B., Golshayan D., Tibbott R., Salcido Ochoa F., James M.J., Marelli-Berg F.M., Lechler R.I. A novel pathway of alloantigen presentation by dendritic cells. J. Immunol. 2004, 173:4828-4837.
18. Marcenaro E., Cantoni C., Pesce S., Prato C., Pende D., Agaugue S., Moretta L., Moretta A. Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood 2009, 114:4108-4116.
19. Nakayama M., Takeda K., Kawano M., Takai T., Ishii N., Ogasawara K. Natural killer (NK)-dendritic cell interactions generate MHC class II-dressed NK cells that regulate CD4+ T cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18360-18365.
20. Russo V., Zhou D., Sartirana C., Rovere P., Villa A., Rossini S., Traversari C., Bordignon C. Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells. Blood 2000, 95:3473-3477.
21. Dolan B.P., Gibbs K.D., Ostrand-Rosenberg S. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. J. Immunol. 2006, 177:6018-6024.
22. Dolan B.P., Gibbs K.D., Ostrand-Rosenberg S. Tumor-specific CD4+ T cells are activated by cross-dressed dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. J. Immunol. 2006, 176:1447-1455.
23. Ferlazzo G., Semino C., Meta M., Procopio F., Morandi B., Melioli G. T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties. Eur. J. Immunol. 2002, 32:3092-3101.
24. Huang J.F., Yang Y., Sepulveda H., Shi W., Hwang I., Peterson P.A., Jackson M.R., Sprent J., Cai Z. TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science 1999, 286:952-954.
25. Hwang I., Huang J.F., Kishimoto H., Brunmark A., Peterson P.A., Jackson M.R., Surh C.D., Cai Z., Sprent J. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 2000, 191:1137-1148.
26. Harshyne L.A., Watkins S.C., Gambotto A., Barratt-Boyes S.M. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. 2001, 166:3717-3723.
27. Fevrier B., Raposo G. Exosomes endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 2004, 16:415-421.
28. Potolicchio I., Carven G.J., Xu X., Stipp C., Riese R.J., Stern L.J., Santambrogio L. Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J. Immunol. 2005, 175:2237-2243.
29. Faure J., Lachenal G., Court M., Hirrlinger J., Chatellard-Causse C., Blot B., Grange J., Schoehn G., Goldberg Y., Boyer V., Kirchhoff F., Raposo G., Garin J., Sadoul R. Exosomes are released by cultured cortical neurones. Mol. Cell Neurosci. 2006, 31:642-648.
30. Andre F., Schartz N.E., Movassagh M., Flament C., Pautier P., Morice P., Pomel C., Lhomme C., Escudier B., Le Chevalier T., Tursz T., Amigorena S., Raposo G., Angevin E., Zitvogel L. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002, 360:295-305.
31. Wolfers J., Lozier A., Raposo G., Regnault A., Thery C., Masurier C., Flament C., Pouzieux S., Faure F., Tursz T., Angevin E., Amigorena S., Zitvogel L. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 2001, 7:297-303.
32. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9:581-593.
33. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., Geuze H.J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183:1161-1172.
34. Bedford P., Garner K., Knight S.C. MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions. Int. Immunol. 1999, 11:1739-1744.
35. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., Ricciardi-Castagnoli P., Raposo G., Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 1998, 4:594-600.
36. Chaput N., Schartz N.E., Andre F., Taieb J., Novault S., Bonnaventure P., Aubert N., Bernard J., Lemonnier F., Merad M., Adema G., Adams M., Ferrantini M., Carpentier A.F., Escudier B., Tursz T., Angevin E., Zitvogel L. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 2004, 172:2137-2146.
37. Segura E., Guerin C., Hogg N., Amigorena S., Thery C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J. Immunol. 2007, 179:1489-1496.
38. Wakim L.M., Bevan M.J. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 2011, 471:629-632.
39. Watkins S.C., Salter R.D. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 2005, 23:309-318.
40. Gerdes H.H., Carvalho R.N. Intercellular transfer mediated by tunneling nanotubes. Curr. Opin. Cell Biol. 2008, 20:470-475.
41. Schiller C., Huber J.E., Diakopoulos K.N., Weiss E.H. Tunneling nanotubes enable intercellular transfer of MHC class I molecules. Hum. Immunol. 2013, 74:412-416.
42. Millet V., Naquet P., Guinamard R.R. Intercellular MHC transfer between thymic epithelial and dendritic cells. Eur. J. Immunol. 2008, 38:1257-1263.
43. Nolte-'t Hoen E.N., Buschow S.I., Anderton S.M., Stoorvogel W., Wauben M.H. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 2009, 113:1977-1981.
44. Bevan M.J. Cross-priming. Nat. Immunol. 2006, 7:363-365.
45. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., Parish I.A., Davey G.M., Wilson N.S., Carbone F.R., Villadangos J.A. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 2004, 199:9-26.
46. Yewdell J.W., Haeryfar S.M. Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 2005, 23:651-682.
47. Smyth L.A., Harker N., Turnbull W., El-Doueik H., Klavinskis L., Kioussis D., Lombardi G., Lechler R. The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type. J. Immunol. 2008, 181:3212-3220.
48. Smyth L.A., Hervouet C., Hayday T., Becker P.D., Ellis R., Lechler R.I., Lombardi G., Klavinskis L.S. Acquisition of MHC: peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo. J. Immunol. 2012, 189:2274-2282.
49. Li L., Kim S., Herndon J.M., Goedegebuure P., Belt B.A., Satpathy A.T., Fleming T.P., Hansen T.H., Murphy K.M., Gillanders W.E. Cross-dressed CD8alpha+/CD103+ dendritic cells prime CD8+ T cells following vaccination. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12716-12721.
50. Bonaccorsi I., Pezzino G., Morandi B., Ferlazzo G. Drag cells in immunity: plasmacytoid DCs dress up as cancer cells. Oncoimmunology 2014, 3:e28184.
51. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999, 5:919-923.
52. Dzionek A., Sohma Y., Nagafune J., Cella M., Colonna M., Facchetti F., Gunther G., Johnston I., Lanzavecchia A., Nagasaka T., Okada T., Vermi W., Winkels G., Yamamoto T., Zysk M., Yamaguchi Y., Schmitz J. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 2001, 194:1823-1834.
53. Bonaccorsi I., Cantoni C., Carrega P., Oliveri D., Lui G., Conte R., Navarra M., Cavaliere R., Traggiai E., Gattorno M., Martini A., Mingari M.C., Moretta A., Ferlazzo G. The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNalpha production. PLoS One 2010, 5:e15080.
54. Dalgaard J., Beckstrom K.J., Jahnsen F.L., Brinchmann J.E. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets. J. Leukoc. Biol. 2005, 77:689-698.
55. Cresswell P. Assembly transport, and function of MHC class II molecules. Annu. Rev. Immunol. 1994, 12:259-293.
56. Markey K.A., Koyama M., Gartlan K.H., Leveque L., Kuns R.D., Lineburg K.E., Teal B.E., MacDonald K.P., Hill G.R. Cross-dressing by donor dendritic cells after allogeneic bone marrow transplantation contributes to formation of the immunological synapse and maximizes responses to indirectly presented antigen. J. Immunol. 2014, 192:5426-5433.
57. Koble C., Kyewski B. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J. Exp. Med. 2009, 206:1505-1513.
58. Helft J., Jacquet A., Joncker N.T., Grandjean I., Dorothee G., Kissenpfennig A., Malissen B., Matzinger P., Lantz O. Antigen-specific T-T interactions regulate CD4 T-cell expansion. Blood 2008, 112:1249-1258.
59. Tsang J.Y., Chai J.G., Lechler R. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?. Blood 2003, 101:2704-2710.
60. Game D.S., Rogers N.J., Lechler R.I. Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. Am. J. Transpl. 2005, 5:1614-1625.
61. Tatari-Calderone Z., Semnani R.T., Nutman T.B., Schlom J., Sabzevari H. Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction. J. Immunol. 2002, 169:6162-6169.
62. Dubrot J., Duraes F.V., Potin L., Capotosti F., Brighouse D., Suter T., LeibundGut-Landmann S., Garbi N., Reith W., Swartz M.A., Hugues S. Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4(+) T cell tolerance. J. Exp. Med. 2014, 211:1153-1166.
63. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N., Mebius R.E., Powrie F., Vivier E. Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 2013, 13:145-149.
64. Oliphant C.J., Hwang Y.Y., Walker J.A., Salimi M., Wong S.H., Brewer J.M., Englezakis A., Barlow J.L., Hams E., Scanlon S.T., Ogg G.S., Fallon P.G., McKenzie A.N. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014, 41:283-295.
65. Carrega P., Loiacono F., Di Carlo E., Scaramuccia A., Mora M., Conte R., Benelli R., Spaggiari G.M., Cantoni C., Campana S., Bonaccorsi I., Morandi B., Truini M., Mingari M.C., Moretta L., Ferlazzo G. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat. Commun. 2015, 6:8280.
66. Feldmann M. Molecular mechanisms involved in human autoimmune diseases: relevance of chronic antigen presentation. Class II expression and cytokine production. Immunol. Suppl. 1989, 2:66-71. discussion 72-63.
67. Bonaccorsi I., De Pasquale C., Campana S., Barberi C., Cavaliere R., Benedetto F., Ferlazzo G. Natural killer cells in the innate immunity network of atherosclerosis. Immunol. Lett. 2015, 168:51-57.
68. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
69. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 2012, 12:557-569.
70. Amar Y., Rizzello V., Cavaliere R., Campana S., De Pasquale C., Barberi C., Oliveri D., Pezzino G., Costa G., Meddah A.T., Ferlazzo G., Bonaccorsi I. Divergent signaling pathways regulate IL-12 production induced by different species of Lactobacilli in human dendritic cells. Immunol. Lett. 2015, 166:6-12.
71. Bonaccorsi I., Pezzino G., Morandi B., Ferlazzo G. Novel perspectives on dendritic cell-based immunotherapy of cancer. Immunol. Lett. 2013, 155:6-10.
72. Toes R.E., Nussbaum A.K., Degermann S., Schirle M., Emmerich N.P., Kraft M., Laplace C., Zwinderman A., Dick T.P., Muller J., Schonfisch B., Schmid C., Fehling H.J., Stevanovic S., Rammensee H.G., Schild H. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 2001, 194:1-12.
73. Emmerich N.P., Nussbaum A.K., Stevanovic S., Priemer M., Toes R.E., Rammensee H.G., Schild H. The human 26 S and 20 S proteasomes generate overlapping but different sets of peptide fragments from a model protein substrate. J. Biol. Chem. 2000, 275:21140-21148.
74. Kloetzel P.M. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat. Immunol. 2004, 5:661-669.
75. Akiyama K., Yokota K., Kagawa S., Shimbara N., Tamura T., Akioka H., Nothwang H.G., Noda C., Tanaka K., Ichihara A. cDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y. Science 1994, 265:1231-1234.
76. Dannull J., Lesher D.T., Holzknecht R., Qi W., Hanna G., Seigler H., Tyler D.S., Pruitt S.K. Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity. Blood 2007, 110:4341-4350.